Koen Van Besien to Ribavirin
This is a "connection" page, showing publications Koen Van Besien has written about Ribavirin.
Connection Strength
0.142
-
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data. Leuk Lymphoma. 2018 01; 59(1):256-258.
Score: 0.142
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.